WINNIPEG, Aug. 6 /CNW/ - IMRIS (TSX: IM) announced today that it will be
installing its fully integrated intraoperative imaging suite IMRISneuro at
Central DuPage Hospital (CDH) in Winfield, Illinois, a suburb west of Chicago.
Installation of this leading edge technology is planned for early 2009.
CDH, one of the fastest growing hospitals in the region, will be the
first in Chicago to implement this revolutionary imaging technology.
Recognized nationally as a leader in technology and patient safety, CDH has
made IMRISneuro an integral component in the continued expansion of its
Central DuPage Hospital will be one of only 18 hospitals in the world to
house IMRISneuro; a fully integrated operating room that combines a
one-of-a-kind movable high-field MRI with the IMRIS surgical information
"This technology is a distinct advantage for our patients and surgeons,"
said Vice President of Operations at CDH, Robert Friedberg. "Nowhere else in
the Chicago region is there an operating room facility that merges the
capabilities of a high field magnet with a state of the art neuro-operating
room. Surgeons will be able to scan patients while still in the operating
room, and determine the extent or completion of tumor removal. Patients will
be able to have the confidence that their surgeon has this great additional
tool to help them on the road to recovery."
"We are confident that in the hands of the surgeons at Central DuPage
Hospital, IMRISneuro will make a major contribution towards providing Chicago
area patients with the highest standard of neuroscience treatment and care,"
said IMRIS President and Chief Executive Officer David Graves.
IMRISneuro does not require the patient to be transported for scanning,
so the optimum position for neurosurgery is never compromised. Clinical
workflow and surgical access to the patient is not impacted and the magnet is
removed completely from the operating room when scanning is complete.
According to Taras Masnyk, MD of the Neurosciences Institute at CDH,
"Being able to remove more of the tumor, or being able to see that the tumor
is completely removed before closing will favorably impact the long-term
survivability of these critically ill patients."
About IMRIS: IMRIS (TSX: IM) is a global leader in providing fully
integrated, advanced surgical imaging solutions designed to measurably improve
patient outcomes. The company's flagship product, IMRISneuro, utilizes
patented technology that allows a high field MRI scanner to move in to the
operating room on demand, providing imaging during the surgical procedure
without compromising patient safety. This unique and innovative system has
been validated by leading neurosurgeons around the world for use in
world-class neuroscience centers.
For more information, visit www.imris.com
About Central DuPage Hospital: Central DuPage Hospital (CDH) is a
nationally recognized 313-bed facility located in Winfield, Illinois, a suburb
west of Chicago. This regional referral center houses the Neurosciences
Institute at CDH, covering a full range of neurosciences care, as well as
innovation and research. With continuous specialized neurology, neurosurgery
and interventional neuroradiology coverage, the Neurosciences Institute at CDH
is one of the region's largest and most comprehensive stroke and epilepsy
centers. CDH, a leader in technology and innovation, is one of the largest
performers of surgery in Illinois.
The hospital is part of an interdependent network of health-care
organizations and services, including convenient care centers, occupational
health services and a full range of options for senior living, home health and
hospice care. To learn more information about CDH, visit www.cdh.org or call
For further information:
For further information: Susan McLeod, Marketing Communications, IMRIS,
Tel: (204) 480-7094, Email: email@example.com; Central DuPage Hospital
contact: Amy Jo Steinbruecker, Tel: (630) 933-5117, firstname.lastname@example.org